Induction Chemoimmunotherapy in Combination With Chemoradiotherapy and Consolidation Immunotherapy in Unresectable Locally Advanced Non-Small Cell Lung Cancer

Clinical trial NCT07632365 · RECRUITING

Trial details

NCT number: NCT07632365
Sponsor: Shanghai Chest Hospital
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer Locally Advanced Non-Small Cell Lung Cancer Unresectable Stage III NSCLC

Start date: 2022-10-09
Primary completion: 2028-12-31
Enrollment: 108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.